Early postnatal cardiac follow-up of survivors of twin-twin transfusion syndrome treated with fetoscopic laser coagulation

J Perinatol. 2020 Sep;40(9):1375-1382. doi: 10.1038/s41372-020-0645-x. Epub 2020 Mar 9.

Abstract

Objective: To assess the cardiac function and prevalence of congenital heart defects (CHD) in twin-twin transfusion syndrome (TTTS) survivors.

Study design: Prospective follow-up of TTTS pregnancies treated with laser surgery (2015-2018). Echocardiography was performed 1 day and 1 month after birth (corrected for prematurity). Results were compared with a control group of age-matched uncomplicated monochorionic twin-pairs at 1 month.

Result: Eighty-nine TTTS (168 neonates) and nine control pregnancies (18 neonates) were enrolled. CHD birth prevalence was 9.2% (8/87) in recipients and 13.6% (11/81) in donors (p = 0.37). Four of 19 (21%) were detected prenatally, all pulmonary stenosis. Donors had lower aortic peak velocities compared with recipients at day 1 (0.66 ± 0.15 m/s vs 0.71 ± 0.19 m/s, p = 0.04) and 1 month (1.04 ± 0.21 m/s vs 1.11 ± 0.18 m/s, p = 0.02), but not compared with controls.

Conclusion: CHD prevalence in TTTS survivors is high, with a low prenatal detection of minor abnormalities. Follow-up fetal echocardiograms and a postnatal echocardiogram should be offered.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Female
  • Fetofetal Transfusion* / diagnostic imaging
  • Fetofetal Transfusion* / epidemiology
  • Fetofetal Transfusion* / surgery
  • Follow-Up Studies
  • Gestational Age
  • Humans
  • Infant, Newborn
  • Laser Coagulation
  • Laser Therapy*
  • Pregnancy
  • Prospective Studies
  • Survivors